Insights

Strategic Market Presence Ewopharma's long-standing focus on Central Eastern European markets coupled with its deep regional understanding presents a significant opportunity to expand sales in these high-growth territories. Leveraging its established distribution channels and local expertise can facilitate the introduction of new pharmaceutical products and proprietary brands.

Recent Acquisitions The company's recent acquisitions of Allergycare and Neomed demonstrate active expansion and diversification, creating sales opportunities for healthcare and allergy-related products. These acquisitions open avenues for cross-selling and integrating additional product lines into Ewopharma’s distribution network.

Partnership Initiatives Ewopharma's strategic collaborations with innovative biopharmaceutical companies like CStone Pharma and distribution partners such as Newport Pharmaceuticals indicate openness to joint ventures. Engaging with these partners offers scope to co-develop and sell new therapies, especially in oncology and specialty medicines.

Digital Engagement Ewopharma's utilization of modern technology platforms like TYPO3, WhatsApp Business, and cloud-based security tools suggests a focus on digital marketing and customer engagement. This digital maturity can be leveraged to approach healthcare professionals and hospitals more effectively for new sales campaigns.

Ewopharma Tech Stack

Ewopharma uses 8 technology products and services including TYPO3, Font Awesome, Parsley.js, and more. Explore Ewopharma's tech stack below.

  • TYPO3
    Content Management System
  • Font Awesome
    Font Scripts
  • Parsley.js
    Frameworks And Libraries
  • Swiper
    Javascript Libraries
  • WhatsApp Business
    Live Chat
  • Google Maps
    Maps
  • Cloudflare Bot Management
    Security
  • X-UA-Compatible
    Web Tools And Plugins

Media & News

Ewopharma's Email Address Formats

Ewopharma uses at least 1 format(s):
Ewopharma Email FormatsExamplePercentage
F.Last@ewopharma.comJ.Doe@ewopharma.com
49%
FLast@ewopharma.comJDoe@ewopharma.com
1%
First@ewopharma.comJohn@ewopharma.com
1%
F.Last@ewopharma.comJ.Doe@ewopharma.com
49%

Frequently Asked Questions

Where is Ewopharma's headquarters located?

Minus sign iconPlus sign icon
Ewopharma's main headquarters is located at 43 Vordergasse Schaffhausen, Schaffhausen 8200 Switzerland. The company has employees across 2 continents, including EuropeNorth America.

What is Ewopharma's official website and social media links?

Minus sign iconPlus sign icon
Ewopharma's official website is ewopharma.com and has social profiles on LinkedIn.

What is Ewopharma's NAICS code?

Minus sign iconPlus sign icon
Ewopharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Ewopharma have currently?

Minus sign iconPlus sign icon
As of February 2026, Ewopharma has approximately 366 employees across 2 continents, including EuropeNorth America. Key team members include Chairman Of The Board And Ceo: A. S.Director Business Development & Specialty Pharma (executive Board Member Of Ewopharma Group): R. A. S.Director Marketing And Consumer Health: A. M.. Explore Ewopharma's employee directory with LeadIQ.

What industry does Ewopharma belong to?

Minus sign iconPlus sign icon
Ewopharma operates in the Pharmaceutical Manufacturing industry.

What technology does Ewopharma use?

Minus sign iconPlus sign icon
Ewopharma's tech stack includes TYPO3Font AwesomeParsley.jsSwiperWhatsApp BusinessGoogle MapsCloudflare Bot ManagementX-UA-Compatible.

What is Ewopharma's email format?

Minus sign iconPlus sign icon
Ewopharma's email format typically follows the pattern of F.Last@ewopharma.com. Find more Ewopharma email formats with LeadIQ.

When was Ewopharma founded?

Minus sign iconPlus sign icon
Ewopharma was founded in 1959.

Ewopharma

Pharmaceutical ManufacturingSchaffhausen, Switzerland201-500 Employees

Ewopharma is the successor company to M.R. Leclerc & Co., founded in 1959. From the start, our focus has been on building bridges to the pharmaceutical markets of Central Eastern Europe. Much has changed in the region since 1959 – both economically and politically – and over this period we have gained an in-depth understanding of the markets and an esteemed standing there.
While we started out purely as a marketing partner for pharmaceutical companies, we have since acquired and launched proprietary products. Our brand Revalid® – a product line for holistic hair care and hair loss treatment–was developed in 1992 in Switzerland. In 2011, we acquired Irish healthcare company Newport Pharmaceuticals Ltd. giving us full ownership of the antiviral drug Isoprinosine® in 2011.Overseen by our head office in Schaffhausen, Switzerland, we now channel our industry knowledge and experience into the successful placement of both Ewopharma and partner brands in our target markets. In 2004, we joined the RX-Alliance, a professional cooperation network of successful pharmaceutical companies active in selected European markets.

Section iconCompany Overview

Headquarters
43 Vordergasse Schaffhausen, Schaffhausen 8200 Switzerland
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1959
Employees
201-500

Section iconFunding & Financials

  • $100M$250M

    Ewopharma's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Ewopharma's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.